George A. Samuel III, General Counsel at Lineage Cell Therapeutics, Inc. (LCTX), bought 15,000 shares at $0.60 ($9K) on 2024-11-26, disclosed to the SEC on 2024-11-26.
Open-market purchase of $9k LCTX by General Counsel. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.